Cofinimmo (COFB) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Net result from core activities (EPRA Earnings) up 3% to €182M; net result group share up 9% to €42M compared to the same period last year.
Portfolio valued at €6.2B, with 75% invested in healthcare real estate across nine countries; office portfolio focused on Brussels CBD, setting new prime rent records.
High occupancy rate of 98.3% and long average lease term of 13 years; strong sustainability recognition with multiple awards and certifications.
Gross dividend outlook for 2024 confirmed at €6.20/share; targeting EPRA EPS > €6.40/share.
Financial highlights
Gross rental revenues up 2.3% year-over-year; like-for-like growth of 2.1%; operating margin at 83.7%.
Net result from core activities per share at €4.88 (includes -€0.80/share from divestments and capital increases).
Debt-to-assets ratio at 44.7% as of 30.09.2024; average cost of debt remains low at 1.4%.
EPRA Net Initial Yield at 5.6%; EPRA vacancy rate at 1.8%.
Portfolio fair value change limited to -0.3% in Q3, indicating stabilisation.
Outlook and guidance
2024 net result from core activities (EPRA EPS) expected to exceed €6.40/share; gross dividend for 2024 confirmed at €6.20/share.
Debt-to-assets ratio expected below 44% by year-end.
Net-zero investment target for 2024, with €215M gross investments offset by €215M divestments.
Average cost of debt projected to remain around 1.5%.
Latest events from Cofinimmo
- 2025 outperformed outlook with robust healthcare focus, high occupancy, and low debt ratio.COFB
Q4 202520 Feb 2026 - Healthcare assets drive 4% earnings growth and 2024 guidance confirmation.COFB
Q2 20242 Feb 2026 - 2024 results beat expectations with a healthcare-focused portfolio and strong financials.COFB
Q4 202416 Dec 2025 - Core earnings up 2% to €186M, 98.6% occupancy, 2025 EPS ≥€6.20/share confirmed.COFB
Q3 202524 Oct 2025 - Core earnings up 2.4%, 98.6% occupancy, 2025 EPS ≥€6.20, dividend €5.20.COFB
Q2 202525 Jul 2025 - Core earnings up 5% in Q1 2025, driven by healthcare and strong occupancy.COFB
Q1 20256 Jun 2025